0001209191-21-057937.txt : 20210928
0001209191-21-057937.hdr.sgml : 20210928
20210928164659
ACCESSION NUMBER: 0001209191-21-057937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210924
FILED AS OF DATE: 20210928
DATE AS OF CHANGE: 20210928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frohlich Tom
CENTRAL INDEX KEY: 0001823925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 211287695
MAIL ADDRESS:
STREET 1: C/O CHINOOK THERAPEUTICS U.S., INC.
STREET 2: 1600 FAIRVIEW AVE. E.
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHINOOK THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 FAIRVIEW AVE E.
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-485-7051
MAIL ADDRESS:
STREET 1: 1600 FAIRVIEW AVE E.
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH, INC.
DATE OF NAME CHANGE: 20111107
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-24
0
0001435049
CHINOOK THERAPEUTICS, INC.
KDNY
0001823925
Frohlich Tom
C/O CHINOOK THERAPEUTICS, INC.
1600 FAIRVIEW AVE. E.
SEATTLE
WA
98102
0
1
0
0
Chief Operating Officer
Common Stock
2021-09-24
4
M
0
20000
0.42
A
153398
D
Employee Stock Option (right to buy)
0.42
2021-09-24
4
M
0
20000
0.00
D
2030-03-17
Common Stock
20000
78847
D
The stock option vests as to 25% of the total shares on March 6, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully
vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Kirk Schumacher, Attorney-in-Fact
2021-09-28